Pathogenic or likely pathogenic variants identified in 197 HLH patients with a definite genetic diagnosis
Patient no. . | Sex . | Age at testing, y (unless indicated otherwise) . | Ethnicity . | Gene . | Variant . | Zygosity . | Population frequency (gnomAD*), % . | Symptoms/immunology testing/family history† . |
---|---|---|---|---|---|---|---|---|
1 | Female | 53 d | African American | PRF1 | c.50del(p.Leu17fs) | Homozygous | 0.033 | Symptoms of HLH |
2 | Male | 63 d | Unknown | PRF1 | c.50del(p.Leu17fs) | Homozygous | 0.033 | Symptoms of HLH |
3 | Male | 0.4 | Middle Eastern | PRF1 | c.50del(p.Leu17fs) | Homozygous | 0.033 | Symptoms of HLH |
4 | Female | 27 d | Unknown | PRF1 | c.50del(p.Leu17fs) | Homozygous | 0.033 | Absent perforin expression |
5 | Female | 32 d | African American | PRF1 | c.50del(p.Leu17fs) | Homozygous | 0.033 | Absent perforin expression |
6 | Male | 4 d | African American | PRF1 | c.50del(p.Leu17fs) | Homozygous | 0.033 | Absent perforin expression; sibling died of HLH |
7 | Female | 0.4 | African American | PRF1 | c.50del(p.Leu17fs) | Homozygous | 0.033 | Symptoms of HLH |
8 | Male | 6 d | African American + European-white | PRF1 | c.50del(p.Leu17fs) | Homozygous | 0.033 | Absent perforin expression |
9 | Male | 59 d | African American | PRF1 | c.50del(p.Leu17fs) | Homozygous | 0.033 | Symptoms of HLH |
10 | Male | 13 d | African | PRF1 | c.50del(p.Leu17fs) | Homozygous | 0.033 | Symptoms of HLH |
11 | Female | 7 d | Unknown | PRF1 | c.50del(p.Leu17fs) | Heterozygous | 0.033 | Absent NK cell function |
PRF1 | c.266C>T(p.Pro89Leu) | Heterozygous | ND | |||||
12 | Female | 0.3 | African American | PRF1 | c.50del(p.Leu17fs) | Heterozygous | 0.033 | NA |
PRF1 | c.350_356delinsATGC (p.Val117_Arg119delinsAspAla) | Heterozygous | ND | |||||
13 | Male | 0.4 | Unknown | PRF1 | c.50del(p.Leu17fs) | Heterozygous | 0.033 | NA |
PRF1 | c.445G>A(p.Gly149Ser) | Heterozygous | 0.014 | |||||
14 | Male | 3.3 | African American | PRF1 | c.50del(p.Leu17fs) | Heterozygous | 0.033 | Absent perforin expression; brother with HLH |
PRF1 | c.527G>A(p.Cys176Tyr) | Heterozygous | ND | |||||
15 | Female | 0.5 | Latino-Hispanic | PRF1 | c.50del(p.Leu17fs) | Heterozygous | 0.033 | Absent perforin expression |
PRF1 | c.659G>A(p.Gly220Asp) | Heterozygous | 0.0008 | |||||
16 | Female | 0.2 | African American | PRF1 | c.50del(p.Leu17fs) | Heterozygous | 0.033 | Absent NK cell function |
PRF1 | c.853_855del(p.Lys285del) | Heterozygous | 0.0056 | |||||
17 | Male | 66 d | Unknown | PRF1 | c.50del(p.Leu17fs) | Heterozygous | 0.033 | NA |
PRF1 | c.895C>T(p.Arg299Cys) | Heterozygous | 0.0012 | |||||
18 | Male | 20.6 | Latino-Hispanic | PRF1 | c.50del(p.Leu17fs) | Heterozygous | 0.033 | NA |
PRF1 | c.902C>T(p.Ser301Leu) | Heterozygous | ND | |||||
19 | Male | 54 d | African American | PRF1 | c.50del(p.Leu17fs) | Heterozygous | 0.033 | Symptoms of HLH |
PRF1 | c.916G>T(p.Gly306Cys) | Heterozygous | ND | |||||
20 | Female | 45 d | African American | PRF1 | c.50del(p.Leu17fs) | Heterozygous | 0.033 | Absent perforin expression |
PRF1 | c.916G>T(p.Gly306Cys) | Heterozygous | ND | |||||
21 | Male | 32 d | Latino-Hispanic | PRF1 | c.50del(p.Leu17fs) | Heterozygous | 0.033 | Symptoms of HLH |
PRF1 | c.985dup(p.Val329fs) | Heterozygous | ND | |||||
22 | Male | 0.3 | African American | PRF1 | c.50del(p.Leu17fs) | Heterozygous | 0.033 | Absent perforin expression |
PRF1 | c.1385C>A(p.Ser462*) | Heterozygous | ND | |||||
23 | Male | 36.1 | Unknown | PRF1 | c.116C>A(p.Pro39His) | Heterozygous | 0.00081 | NA |
PRF1 | c.445G>A(p.Gly149Ser) | Heterozygous | 0.014 | |||||
24 | Female | 1.2 | Asian-American | PRF1 | c.133G>A(p.Gly45Arg) | Homozygous | 0.0012 | Absent NK cell function |
25 | Female | 37 d | Non-Hispanic white | PRF1 | c.150del(p.Thr51fs) | Heterozygous | 0.0004 | Absent perforin expression |
PRF1 | c.227G>A(p.Cys76Tyr) | Heterozygous | 0.00071 | |||||
26 | Male | 69 d | Latino-Hispanic | PRF1 | c.218G>C(p.Cys73Ser) | Homozygous | 0.0004 | Symptoms of HLH |
27 | Female | 20 | European-American | PRF1 | c.227G>A(p.Cys76Tyr) | Heterozygous | 0.00071 | Absent perforin expression |
PRF1 | c.626A>C(p.Gln209Pro) | Heterozygous | 0.0012 | |||||
28 | Female | 21.8 | Unknown | PRF1 | c.272C>T(p.Ala91Val)‡ | Heterozygous | 2.92 | Absent NK cell function, decreased perforin expression |
PRF1 | c.445G>A(p.Gly149Ser) | Heterozygous | 0.014 | |||||
29 | Male | 17 | European-American | PRF1 | c.272C>T(p.Ala91Val)‡ | Heterozygous | 2.92 | Absent perforin expression |
PRF1 | c.635A>C(p.Tyr212Ser) | Heterozygous | ND | |||||
30 | Female | 41.2 | European-American | PRF1 | c.272C>T(p.Ala91Val)‡ | Heterozygous | 2.92 | Absent NK cell function, decreased perforin expression |
PRF1 | c.666C>A(p.His222Gln) | Heterozygous | 0.0039 | |||||
31 | Female | 8.3 | European-American | PRF1 | c.443C>G(p.Ala148Gly) | Heterozygous | 0.0004 | NA |
PRF1 | c.666C>A(p.His222Gln) | Heterozygous | 0.0039 | |||||
32 | Male | 2.6 | Unknown | PRF1 | c.445G>A(p.Gly149Ser) | Homozygous | 0.014 | Absent NK cell function |
33 | Male | 0.8 | Latino-Hispanic | PRF1 | c.445G>A(p.Gly149Ser) | Homozygous | 0.014 | Symptoms of HLH |
34 | Female | 6 | Latino-Hispanic | PRF1 | c.445G>A(p.Gly149Ser) | Homozygous | 0.014 | NA |
35 | Female | 0.3 | European-American | PRF1 | c.445G>A(p.Gly149Ser) | Heterozygous | 0.014 | Family history of HLH |
PRF1 | c.614A>G(p.Asn205Ser) | Heterozygous | 0.0043 | |||||
36 | Male | 42 d | Latino-Hispanic | PRF1 | c.445G>A(p.Gly149Ser) | Heterozygous | 0.014 | NA |
PRF1 | c.938A>T(p.Asp313Val) | Heterozygous | 0.0012 | |||||
37 | Male | 4.6 | Unknown | PRF1 | c.445G>A(p.Gly149Ser) | Heterozygous | 0.014 | Absent perforin expression |
PRF1 | c.1081A>T(p.Arg361Trp) | Heterozygous | 0.0011 | |||||
38 | Female | 32 d | Middle Eastern | PRF1 | c.501C>G(p.Tyr167*) | Homozygous | ND | Symptoms of HLH |
39 | Female | 0.3 | Unknown | PRF1 | c.512C>A(p.Thr171Asn) | Homozygous | 0.0028 | Absent perforin expression |
40 | Male | 9.5 | European-American | PRF1 | c.786_801del(p.Gln263fs) | Heterozygous | ND | Absent NK cell function |
PRF1 | c.886T>C(p.Tyr296His) | Heterozygous | 0.0012 | |||||
41 | Male | 59 d | Unknown | PRF1 | c.853_855del(p.Lys285del) | Heterozygous | 0.0057 | NA |
PRF1 | c.921del(p.His308fs) | Heterozygous | 0.002 | |||||
42 | Female | 0.7 | Middle Eastern | PRF1 | c.880del(p.Gln294fs) | Homozygous | ND | Symptoms of HLH |
43 | Female | 2 | Middle Eastern | PRF1 | c.895C>T(p.Arg299Cys) | Homozygous | 0.0012 | Symptoms of HLH |
44 | Female | 0.2 | Latino-Hispanic | PRF1 | c.904G>T(p.Glu302*) | Homozygous | ND | Absent perforin expression |
45 | Female | 1.8 | Unknown | PRF1 | c.949G>A(p.Gly317Arg) | Homozygous | 0.0008 | Symptoms of HLH |
46 | Female | 10.3 | European-American | PRF1 | c.973T>C(p.Tyr325His) | Heterozygous | ND | Absent perforin expression |
PRF1 | c.1326_1328del(p.Phe443del) | Heterozygous | ND | |||||
47 | Male | 1.1 | Middle Eastern | PRF1 | c.1070G>C(p.Arg357Pro) | Homozygous | ND | Symptoms of HLH |
48 | Male | 12.5 | Middle Eastern | PRF1 | c.1081A>T(p.Arg361Trp) | Homozygous | 0.0011 | Abnormal brain lesions and seizures |
49 | Female | 2.6 | Unknown | PRF1 | c.1229_1230delinsCC (p.Arg410Pro) | Homozygous | ND | NA |
50 | Female | 0.2 | African American | PRF1 | c.1304C>T(p.Thr435Met) | Heterozygous | 0.0028 | Absent perforin expression |
PRF1 | c.1314T>A(p.Tyr438*) | Heterozygous | 0.0032 | |||||
51 | Female | 2.6 | Latino-Hispanic | PRF1 | c.1337A>C(p.Gln446Pro) | Homozygous | 0.0016 | NA |
52 | Female | 2.6 | Unknown | PRF1 | c.1337A>C(p.Gln446Pro) | Homozygous | 0.0016 | Symptoms of HLH |
53 | Female | 0.4 | Middle Eastern | STXBP2 | c.37+2T>C | Heterozygous | ND | Absent NK cell function |
STXBP2 | c.1430C>T(p.Pro477Leu) | Heterozygous | 0.00074 | |||||
54 | Male | 0.6 | Unknown | STXBP2 | c.37+5G>A | Heterozygous | ND | NA |
STXBP2 | c.1057T>C (p.Cys353Arg) | Heterozygous | 0.0004 | |||||
55 | Female | 63 d | Asian-American | STXBP2 | c.193C>T(p.Arg65Trp) | Homozygous | 0.00071 | Absent NK cell function |
56 | Female | 5.5 | Unknown | STXBP2 | c.194G>A(p.Arg65Gln) | Heterozygous | 0.0028 | Absent NK cell function |
STXBP2 | c.560C>T (p.Pro187Leu) | Heterozygous | 0.00064 | |||||
57 | Male | 4.1 | European-American | STXBP2 | c.194G>A(p.Arg65Gln) | Heterozygous | 0.0028 | Symptoms of HLH |
STXBP2 | c.1621G>A(p.Gly541Ser) | Heterozygous | 0.023 | |||||
58 | Female | 4.2 | European-American | STXBP2 | c.326-30_326-23del | Heterozygous | 0.0068 | Symptoms of HLH |
STXBP2 | c.1621G>A(p.Gly541Ser) | Heterozygous | 0.023 | |||||
59 | Male | 0.6 | Latino-Hispanic | STXBP2 | c.389T>C(p.Leu130Ser) | Homozygous | 0.0032 | Symptoms of HLH |
60 | Male | 45 d | African American | STXBP2 | c.389T>C(p.Leu130Ser) | Heterozygous | 0.0032 | Symptoms of HLH; family history of HLH |
STXBP2 | exon 14-19 deletion | Heterozygous | ND | |||||
61 | Male | 0.7 | Middle Eastern | STXBP2 | c.481del(p.Arg161fs) | Homozygous | ND | Symptoms of HLH |
62 | Male | 0.4 | Unknown | STXBP2 | c.481del(p.Arg161fs) | Homozygous | ND | Symptoms of HLH |
63 | Female | 11 | European-American | STXBP2 | c.539_540delinsAA(p.Cys180*) | Heterozygous | ND | Symptoms of HLH |
STXBP2 | c.1247-1G>C | Heterozygous | 0.02 | |||||
64 | Male | 0.3 | Latino-Hispanic | STXBP2 | c.703C>G(p.Arg235Gly) | Homozygous | 0.00071 | Absent NK cell function |
65 | Female | 52.7 | European-American | STXBP2 | c.752C>T(p.Ala251Val) | Heterozygous | ND | Symptoms of HLH |
STXBP2 | c.1621G>A(p.Gly541Ser) | Heterozygous | 0.023 | |||||
66 | Male | 0.9 | Unknown | STXBP2 | c.902+5G>A | Heterozygous | 0.0036 | NA |
STXBP2 | c.1247-1G>C | Heterozygous | 0.02 | |||||
67 | Male | 3.1 | Unknown | STXBP2 | c.1247-1G>C | Homozygous | 0.02 | Symptoms of HLH |
68 | Female | 22.7 | Latino-Spanish | STXBP2 | c.1247-1G>C | Homozygous | 0.02 | Decreased NK cell function |
69 | Male | 26.4 | European-American | STXBP2 | c.1247-1G>C | Homozygous | 0.02 | Symptoms of HLH |
70 | Male | 25.6 | European-American | STXBP2 | c.1247-1G>C | Homozygous | 0.02 | Symptoms of HLH |
71 | Female | 29.7 | European-American | STXBP2 | c.1247-1G>C | Homozygous | 0.02 | NA |
72 | Male | 4 | European-American | STXBP2 | c.1247-1G>C | Heterozygous | 0.02 | Absent NK cell function |
STXBP2 | c.1621G>A(p.Gly541Ser) | Heterozygous | 0.023 | |||||
73 | Female | 15.8 | European-American | STXBP2 | c.1247-1G>C | Heterozygous | 0.02 | Absent NK cell function |
STXBP2 | c.1621G>A(p.Gly541Ser) | Heterozygous | 0.023 | |||||
74 | Female | 19 | Unknown | STXBP2 | c.1247-1G>C | Heterozygous | 0.02 | Decreased NK cell function |
STXBP2 | c.1621G>A(p.Gly541Ser) | Heterozygous | 0.023 | |||||
75 | Female | 26.9 | European-American | STXBP2 | c.1247-1G>C | Heterozygous | 0.02 | Symptoms of HLH |
STXBP2 | c.1621G>A(p.Gly541Ser) | Heterozygous | 0.023 | |||||
76 | Female | 57.8 | European-American | STXBP2 | c.1247-1G>C | Heterozygous | 0.02 | Absent NK cell function |
STXBP2 | c.1621G>A(p.Gly541Ser) | Heterozygous | 0.023 | |||||
77 | Female | 0.2 | Middle Eastern | STXBP2 | c.1430C>T(p.Pro477Leu) | Homozygous | 0.00074 | Symptoms of HLH |
78 | Female | 0.3 | Middle Eastern | STXBP2 | c.1430C>T(p.Pro477Leu) | Homozygous | 0.00074 | NA |
79 | Female | 0.3 | Middle Eastern | STXBP2 | c.1430C>T(p.Pro477Leu) | Homozygous | 0.00074 | Symptoms of HLH |
80 | Female | 0.6 | Middle Eastern | STXBP2 | c.1430C>T(p.Pro477Leu) | Homozygous | 0.00074 | Symptoms of HLH |
81 | Male | 0.2 | Middle Eastern | STXBP2 | c.1430C>T(p.Pro477Leu) | Homozygous | 0.00074 | NA |
82 | Male | 0.7 | Middle Eastern | STXBP2 | c.1430C>T(p.Pro477Leu) | Homozygous | 0.00074 | Symptoms of HLH |
83 | Female | 0.8 | Middle Eastern | STXBP2 | c.1430C>T(p.Pro477Leu) | Homozygous | 0.00074 | Symptoms of HLH |
84 | Male | 0.8 | Unknown | STXBP2 | c.1430C>T(p.Pro477Leu) | Homozygous | 0.00074 | Symptoms of HLH |
85 | Male | 0.6 | Unknown | STXBP2 | c.1430C>T(p.Pro477Leu) | Homozygous | 0.00074 | Family history of HLH |
86 | Male | 1.6 | Middle Eastern | STXBP2 | c.1430C>T(p.Pro477Leu) | Homozygous | 0.00074 | Symptoms of HLH |
87 | Male | 0.3 | Middle Eastern | STXBP2 | c.1430C>T(p.Pro477Leu) | Homozygous | 0.00074 | Symptoms of HLH |
88 | Female | 63 d | Middle Eastern | STXBP2 | c.1430C>T(p.Pro477Leu) | Homozygous | 0.00074 | Family history of HLH |
89 | Male | 0.5 | Unknown | STXBP2 | c.1430C>T(p.Pro477Leu) | Homozygous | 0.00074 | Symptoms of HLH |
90 | Male | 0.2 | Middle Eastern | STXBP2 | c.1430C>T(p.Pro477Leu) | Homozygous | 0.00074 | Symptoms of HLH |
91 | Male | 11.1 | Unknown | STXBP2 | c.1430C>T(p.Pro477Leu) | Homozygous | 0.00074 | Absent NK cell function |
92 | Female | 10.1 | Unknown | STXBP2 | c.1430C>T(p.Pro477Leu) | Heterozygous | 0.00074 | Symptoms of HLH |
STXBP2 | c.1696+5G>T | Heterozygous | ND | |||||
93 | Male | 0.5 | Middle Eastern | STXBP2 | c.1452+1G>A | Homozygous | ND | Symptoms of HLH |
94 | Male | 1 | Middle Eastern | STXBP2 | c.1452+1G>A | Homozygous | ND | Abnormal NK cell function |
95 | Female | 49 d | European-American | UNC13D | c.118-308C>T | Heterozygous | 0.019 | Dysmorphic facies, decreased NK cell function |
UNC13D | c.2258_2267delinsTACCTTGTTCGA (p.Gly753fs) | Heterozygous | ND | |||||
96 | Male | 0.7 | European-American | UNC13D | c.118-308C>T | Heterozygous | 0.019 | Decreased NK cell function |
UNC13D | c.2346_2349del(p.Arg782fs) | Heterozygous | 0.01 | |||||
97 | Male | 0.2 | European-American + Latino-Spanish | UNC13D | c.118-308C>T | Heterozygous | 0.019 | Decreased NK cell function |
UNC13D | c.2346_2349del(p.Arg782fs) | Heterozygous | 0.01 | |||||
98 | Female | 1.3 | Non-Hispanic white | UNC13D | c.118-308C>T | Heterozygous | 0.019 | Symptoms of HLH, seizures, normal NK cell function |
UNC13D | c.2867C>T(p.Pro956Leu) | Heterozygous | ND | |||||
99 | Female | 1 | Non-Hispanic white | UNC13D | c.118-308C>T | Heterozygous | 0.019 | Absent NK cell function |
UNC13D | c.3193C>T(p.Arg1065*) | Heterozygous | 0.0011 | |||||
100 | Female | 3.2 | European-American | UNC13D | c.118-308C>T | Heterozygous | 0.019 | Absent NK cell function |
UNC13D | 253Kb inversion | Heterozygous | ND | |||||
101 | Male | 2.6 | Unknown | UNC13D | 253Kb inversion | Heterozygous | ND | Decreased NK cell function |
UNC13D | c.154-1G>C | Heterozygous | ND | |||||
102 | Male | 0.2 | Unknown | UNC13D | 253Kb inversion | Heterozygous | ND | Symptoms of HLH |
UNC13D | c.551G>A(p.Trp184*) | Heterozygous | 0.0011 | |||||
103 | Female | 0.2 | European-American | UNC13D | 253Kb inversion | Heterozygous | ND | NA |
UNC13D | c.1389+1G>A | Heterozygous | 0.0071 | |||||
104 | Female | 0.2 | European-American | UNC13D | 253Kb inversion | Heterozygous | ND | Absent NK cell function |
UNC13D | c.2447+1G>A | Heterozygous | 0.00051 | |||||
105 | Female | 0.6 | Non-Hispanic white | UNC13D | 253Kb inversion | Heterozygous | ND | Decreased NK cell function |
UNC13D | c.2695C>T(p.Arg899*) | Heterozygous | 0.0018 | |||||
106 | Male | 11.4 | Hispanic white | UNC13D | c.182A>G(p.Tyr61Cys) | Heterozygous | ND | Symptoms of HLH |
UNC13D | c.778T>C(p.Trp260Arg) | Heterozygous | ND | |||||
107 | Male | 0.4 | European-American | UNC13D | c.262-1G>A | Heterozygous | ND | Symptoms of HLH, abnormal NK cell function, family history of HLH |
UNC13D | c.766C>T(p.Arg256*) | Heterozygous | 0.0025 | |||||
108 | Male | 0.4 | Unknown | UNC13D | c.321+1_321+2del | Heterozygous | ND | Decreased NK cell function |
UNC13D | c.753+1G>T | Heterozygous | 0.0044 | |||||
109 | Male | 0.3 | Unknown | UNC13D | c.322-2A>T | Heterozygous | 0.0024 | Symptoms of HLH, decreased NK cell function |
UNC13D | c.2346_2349del(p.Arg782fs) | Heterozygous | 0.01 | |||||
110 | Male | 0.3 | Unknown | UNC13D | c.419T>C(p.Ile140Thr) | Heterozygous | 0.0004 | NA |
UNC13D | c.460C>T(p.Arg154Trp) | Heterozygous | 0.011 | |||||
111 | Female | 5.4 | Middle Eastern | UNC13D | c.424dup(p.Gln142fs) | Homozygous | ND | Symptoms of HLH |
112 | Male | 7.7 | Latino-Hispanic | UNC13D | c.518C>T(p.Thr173Met) | Heterozygous | 0.0028 | NA |
UNC13D | c.1803_1819dup(p.Arg607fs) | Heterozygous | ND | |||||
113 | Female | 39 d | European-American | UNC13D | c.551G>A(p.Trp184*) | Heterozygous | 0.0011 | Abnormal NK cell function |
UNC13D | c.766C>T(p.Arg256*) | Heterozygous | 0.0025 | |||||
114 | Male | 4.9 | European-American | UNC13D | c.570-2A>T | Heterozygous | ND | Absent NK cell function |
UNC13D | c.3049G>A(p.Glu1017Lys) | Heterozygous | 0.00044 | |||||
115 | Female | 0.2 | Middle Eastern | UNC13D | c.753+1G>T | Homozygous | 0.0044 | Symptoms of HLH |
116 | Female | 0.6 | European-American | UNC13D | c.766C>T(p.Arg256*) | Heterozygous | 0.0025 | Symptoms of HLH, abnormal NK cell function |
UNC13D | c.2447+1G>A | Heterozygous | 0.00051 | |||||
117 | Female | 1.2 | Latino-Spanish | UNC13D | c.859del(p.Arg287fs) | Homozygous | ND | Decreased NK cell function |
118 | Female | 1 | Non-Hispanic white | UNC13D | c.1055+1G>T | Heterozygous | ND | Decreased NK cell function, family history of HLH |
UNC13D | c.2346_2349del(p.Arg782fs) | Heterozygous | 0.01 | |||||
119 | Male | 0.7 | European-American | UNC13D | c.1229_1230dup(p.Arg411fs) | Heterozygous | 0.00 | Symptoms of HLH, hypertelorism |
UNC13D | c.2298+1G>T | Heterozygous | ND | |||||
120 | Female | 0.2 | European-American | UNC13D | c.1259_1260del(p.Ser420fs) | Heterozygous | ND | symptoms of HLH, decreased NK cell function |
UNC13D | c.1848+1G>C | Heterozygous | ND | |||||
121 | Male | 18.3 | European-American | UNC13D | c.1387C>T(p.Gln463*) | Heterozygous | ND | symptoms of HLH, decreased NK cell function |
UNC13D | c.1820G>C(p.Arg607Pro) | Heterozygous | 0.011 | |||||
122 | Female | 58 d | European-American + African American | UNC13D | c.1389+1G>A | Heterozygous | 0.0071 | Symptoms of HLH |
UNC13D | c.1848+1G>C | Heterozygous | ND | |||||
123 | Female | 0.2 | Middle Eastern | UNC13D | c.1423C>T(p.Gln475*) | Homozygous | ND | NA |
124 | Male | 10 d | Pacific Islander | UNC13D | c.2296C>T(p.Gln766*) | Homozygous | ND | Decreased NK cell function |
125 | Female | 13.2 | Unknown | UNC13D | c.2346_2349del(p.Arg782fs) | Heterozygous | 0.01 | NA |
UNC13D | c.2588G>A(p.Gly863Asp) | Heterozygous | 0.029 | |||||
126 | Female | 2 | Unknown | UNC13D | c.2346_2349del(p.Arg782fs) | Heterozygous | 0.01 | NA |
UNC13D | c.3065T>C(p.Leu1022Pro) | Heterozygous | ND | |||||
127 | Female | 0.2 | Middle Eastern | UNC13D | c.2553+1G>T | Homozygous | ND | Symptoms of HLH |
128 | Female | 0.3 | Middle Eastern | UNC13D | c.2553+1G>T | Homozygous | ND | Symptoms of HLH |
129 | Female | 1 | Asian | UNC13D | c.2588G>A(p.Gly863Asp) | Homozygous | 0.029 | Decreased NK cell function |
130 | Female | 0.4 | African American | UNC13D | c.2695C>T(p.Arg899*) | Homozygous | 0.0018 | Symptoms of HLH, absent NK cell function, dysmorphic facies |
131 | Male | 0.7 | Non-Hispanic white | UNC13D | c.2819del(p.Leu940fs) | Homozygous | ND | symptoms of HLH |
132 | Female | 0.6 | Middle Eastern | UNC13D | c.3048dup(p.Glu1017fs) | Homozygous | ND | NA |
133 | Female | 0.7 | Unknown | UNC13D | c.3053C>A(p.Ala1018Asp) | Homozygous | 0.00088 | 2 affected siblings |
134 | Male | 13 | European-American | RAB27A | c.121A>G(p.Thr41Ala) | Heterozygous | ND | NA |
RAB27A | c.352C>T(p.Gln118*) | Heterozygous | ND | |||||
135 | Male | 9.6 | Middle Eastern | RAB27A | c.244C>T(p.Arg82Cys) | Homozygous | 0.0016 | NA |
136 | Male | 9.9 | Middle Eastern | RAB27A | c.244C>T(p.Arg82Cys) | Homozygous | 0.0016 | NA |
137 | Female | 2 | Middle Eastern | RAB27A | c.244C>T(p.Arg82Cys) | Homozygous | 0.0016 | Failure to thrive, bone marrow failure |
138 | Female | 9.4 | Middle Eastern | RAB27A | c.244C>T(p.Arg82Cys) | Homozygous | 0.0016 | Symptoms of HLH |
139 | Male | 10.6 | Middle Eastern | RAB27A | c.244C>T(p.Arg82Cys) | Homozygous | 0.0016 | Symptoms of HLH |
140 | Male | 19.5 | Middle Eastern | RAB27A | c.244C>T(p.Arg82Cys) | Homozygous | 0.0016 | Symptoms of HLH |
141 | Female | 0.3 | Latino-Hispanic | RAB27A | c.335del(p.Asn112fs) | Homozygous | 0.0044 | Symptoms of HLH |
142 | Female | 0.4 | Middle Eastern | RAB27A | c.400A>C(p.Lys134Gln) | Homozygous | ND | NA |
143 | Female | 53.9 | Pacific Islander | RAB27A | c.476A>G(p.Tyr159Cys) | Homozygous | ND | Symptoms of HLH, absent NK cell function |
144 | Male | 1.2 | Middle Eastern | RAB27A | c.598C>T(p.Arg200*) | Homozygous | 0.0004 | NA |
145 | Female | 0.4 | European-American | RAB27A | c.638_642del(p.Glu213fs) | Homozygous | 0.0008 | Symptoms of HLH |
146 | Female | 0.7 | African American | LYST | c.925C>T(p.Arg309*) | Heterozygous | ND | Oculocutaneous albinism, neutropenia |
LYST | c.2015dup(p.Tyr672*) | Heterozygous | ND | |||||
147 | Male | 3.4 | Unknown | LYST | c.3194del(p.Leu1065*) | Homozygous | 0.0004 | NA |
148 | Female | 0.3 | Middle Eastern | LYST | c.4159dup(p.Thr1387fs) | Homozygous | ND | Premature gray hair, anemia |
149 | Male | 0.9 | European-American | LYST | c.5715del(p.Asn1905fs) | Heterozygous | ND | Oculocutaneous albinism, neutropenia, absent NK cell function |
LYST | c.8802-2A>G | Heterozygous | ND | |||||
150 | Female | 6.9 | Unknown | LYST | c.5784+1G>T | Homozygous | ND | Oculocutaneous albinism, dysmorphic facies, neutropenia |
151 | Male | 3.2 | Non-Hispanic white | LYST | c.6159_6160del(p.Met2053fs) | Homozygous | ND | NA |
152 | Male | 1.8 | Middle Eastern | LYST | c.7291del(p.Leu2431fs) | Homozygous | ND | Hypopigmentation, anemia |
153 | Male | 1.2 | African American | LYST | c.8770C>T(p.Gln2924*) | Heterozygous | ND | Silver hair, hypopigmented skin lesions, pancytopenia |
LYST | c.9844_9845del(p.Ser3282fs) | Heterozygous | ND | |||||
154 | Female | 7.1 | Middle Eastern | LYST | c.10776C>G(p.Tyr3592*) | Homozygous | ND | Abnormal pigmentation, neutropenia |
155 | Female | 1.2 | Unknown | STX11 | c.73G>T(p.Glu25*) | Heterozygous | 0.0004 | Decreased NK cell function |
STX11 | c.748C>T(p.Gln250*) | Heterozygous | 0.00081 | |||||
156 | Female | 5.6 | Middle Eastern | STX11 | c.173T>C(p.Leu58Pro) | Homozygous | 0.0008 | Symptoms of HLH, grayish hair |
157 | Female | 11.6 | Middle Eastern | STX11 | c.173T>C(p.Leu58Pro) | Homozygous | 0.0008 | NA |
158 | Male | 2.9 | European-American + Latino-Hispanic | STX11 | c.462_463delinsA(p.Asp155fs) | Heterozygous | ND | Decreased NK cell function |
STX11 | c.784C>T(p.Gln262*) | Heterozygous | ND | |||||
159 | Male | 1.4 | Asian-Indian | STX11 | c.687dup(p.Gln230fs) | Homozygous | ND | NA |
160 | Female | 12 d | Middle Eastern | SLC7A7 | c.1429+1G>C | Homozygous | ND | Family history of HLH |
161 | Male | 1.2 | African American | SLC7A7 | c.701del(p.Ser234fs) | Heterozygous | 0.0016 | NA |
SLC7A7 | c.895-1G>A | Heterozygous | ND | |||||
162 | Female | 13.7 | European-American | SLC7A7 | c.360_361delinsAA (p.Trp121Arg) | Homozygous | ND | NA |
163 | Male | 5.4 | African American | XIAP | c.145C>T(p.Arg49*) | Hemizygous | ND | Markedly decreased XIAP expression |
164 | Male | 18.7 | European-American | XIAP | c.345C>G(p.Tyr115*) | Hemizygous | ND | Symptoms of HLH |
165 | Male | 30.3 | European-American | XIAP | c.608G>T(p.Cys203Phe) | Hemizygous | ND | NA |
166 | Male | 2 | European-American | XIAP | c.664C>T(p.Arg222*) | Hemizygous | ND | Symptoms of HLH |
167 | Male | 8.9 | European-American | XIAP | c.738del(p.Asp247fs) | Hemizygous | ND | NA |
168 | Male | 16 | European-American | XIAP | c.738del(p.Asp247fs) | Hemizygous | ND | Absent XIAP expression |
169 | Male | 3.6 | African American | XIAP | c.889A>T(p.Lys297*) | Hemizygous | ND | NA |
170 | Male | 0.4 | Unknown | XIAP | c.894_898del(p.Lys299fs) | Hemizygous | ND | NA |
171 | Male | 17.2 | European-American | XIAP | c.894_898del(p.Lys299fs) | Hemizygous | ND | Symptoms of HLH |
172 | Male | 19.6 | African American | XIAP | c.926_929del(p.Asp309fs) | Hemizygous | ND | Symptoms of HLH |
173 | Male | 17.2 | European-American | XIAP | c.969G>A(p.Trp323*) | Hemizygous | ND | Decreased XIAP expression |
174 | Male | 22.6 | Unknown | XIAP | c.1021_1022del(p.Asn341fs) | Hemizygous | ND | NA |
175 | Male | 4.5 | Unknown | XIAP | c.1056+1G>A | Hemizygous | ND | NA |
176 | Male | 2.7 | Latino-Hispanic | XIAP | c.1141C>T(p.Arg381*) | Hemizygous | ND | NA |
177 | Male | 11.8 | Unknown | XIAP | c.1141C>T(p.Arg381*) | Hemizygous | ND | Absent XIAP expression |
178 | Male | 1 d | Pacific-Islander | XIAP | c.1239_1242dup(p.Val415fs) | Hemizygous | ND | Markedly decreased XIAP expression |
179 | Male | 1.9 | Unknown | XIAP | c.1239_1242dup(p.Val415fs) | Hemizygous | ND | NA |
180 | Male | 1.1 | Unknown | XIAP | c.1301-1G>A | Hemizygous | ND | Symptoms of HLH |
181 | Male | 1.5 | Unknown | XIAP | c.1445C>G(p.Pro482Arg) | Hemizygous | ND | NA |
182 | Male | 35 | European-American | XIAP | c.1456dup(p.Thr486fs) | Hemizygous | ND | Symptoms of HLH |
183 | Male | 4.5 | European-American | SH2D1A | c.20A>G(p.Tyr7Cys) | Hemizygous | ND | Absent SAP in CD8+ T cells |
184 | Male | 1.8 | Unknown | SH2D1A | c.117C>T(p.Gly39Gly) | Hemizygous | ND | NA |
185 | Male | 3.5 | Unknown | SH2D1A | c.130T>C(p.Cys44Arg) | Hemizygous | ND | Absent SAP in CD8+ T cells |
186 | Male | 27 | European-American | SH2D1A | c.163C>T(p.Arg55*) | Hemizygous | ND | History of pneumonia |
187 | Male | 8 d | Unknown | SH2D1A | c.172C>T(p.Gln58*) | Hemizygous | ND | NA |
188 | Male | 6.8 | African American | SH2D1A | c.172C>T(p.Gln58*) | Hemizygous | ND | Absent SAP in CD8+ T cells |
189 | Male | 4.7 | Latino-Hispanic | SH2D1A | c.199_201+19del(p.Glu67del) | Hemizygous | ND | Absent SAP in CD8+ T cells |
190 | Male | 1.3 | African American | SH2D1A | c.201G>A(p.Glu67Glu) | Hemizygous | ND | Absent SAP in CD8+ T cells |
191 | Male | 7 d | European-American | SH2D1A | c.245del(p.Asn82fs) | Hemizygous | ND | Absent SAP in CD8+ T cells |
192 | Male | 34 d | European-American + Pacific-Islander | SH2D1A | c.295C>T(p.Gln99*) | Hemizygous | ND | Absent SAP in CD8+ T cells |
193 | Male | 5.4 | Middle-Eastern | MAGT1 | c.154_161delinsC(p.Ile52fs) | Hemizygous | ND | Symptoms of HLH, bone pain in low extremities |
194 | Male | 10.4 | European-American | MAGT1 | c.223C>T(p.Gln75*) | Hemizygous | ND | NA |
195 | Male | 18.4 | African American | MAGT1 | c.407G>A(p.Trp136*) | Hemizygous | ND | NA |
196 | Male | 27.6 | European-American | MAGT1 | c.443_444del(p.Phe148fs) | Hemizygous | ND | Symptoms of HLH |
197 | Male | 17.3 | European-American | MAGT1 | c.774del(p.Phe258fs) | Hemizygous | ND | NA |
Patient no. . | Sex . | Age at testing, y (unless indicated otherwise) . | Ethnicity . | Gene . | Variant . | Zygosity . | Population frequency (gnomAD*), % . | Symptoms/immunology testing/family history† . |
---|---|---|---|---|---|---|---|---|
1 | Female | 53 d | African American | PRF1 | c.50del(p.Leu17fs) | Homozygous | 0.033 | Symptoms of HLH |
2 | Male | 63 d | Unknown | PRF1 | c.50del(p.Leu17fs) | Homozygous | 0.033 | Symptoms of HLH |
3 | Male | 0.4 | Middle Eastern | PRF1 | c.50del(p.Leu17fs) | Homozygous | 0.033 | Symptoms of HLH |
4 | Female | 27 d | Unknown | PRF1 | c.50del(p.Leu17fs) | Homozygous | 0.033 | Absent perforin expression |
5 | Female | 32 d | African American | PRF1 | c.50del(p.Leu17fs) | Homozygous | 0.033 | Absent perforin expression |
6 | Male | 4 d | African American | PRF1 | c.50del(p.Leu17fs) | Homozygous | 0.033 | Absent perforin expression; sibling died of HLH |
7 | Female | 0.4 | African American | PRF1 | c.50del(p.Leu17fs) | Homozygous | 0.033 | Symptoms of HLH |
8 | Male | 6 d | African American + European-white | PRF1 | c.50del(p.Leu17fs) | Homozygous | 0.033 | Absent perforin expression |
9 | Male | 59 d | African American | PRF1 | c.50del(p.Leu17fs) | Homozygous | 0.033 | Symptoms of HLH |
10 | Male | 13 d | African | PRF1 | c.50del(p.Leu17fs) | Homozygous | 0.033 | Symptoms of HLH |
11 | Female | 7 d | Unknown | PRF1 | c.50del(p.Leu17fs) | Heterozygous | 0.033 | Absent NK cell function |
PRF1 | c.266C>T(p.Pro89Leu) | Heterozygous | ND | |||||
12 | Female | 0.3 | African American | PRF1 | c.50del(p.Leu17fs) | Heterozygous | 0.033 | NA |
PRF1 | c.350_356delinsATGC (p.Val117_Arg119delinsAspAla) | Heterozygous | ND | |||||
13 | Male | 0.4 | Unknown | PRF1 | c.50del(p.Leu17fs) | Heterozygous | 0.033 | NA |
PRF1 | c.445G>A(p.Gly149Ser) | Heterozygous | 0.014 | |||||
14 | Male | 3.3 | African American | PRF1 | c.50del(p.Leu17fs) | Heterozygous | 0.033 | Absent perforin expression; brother with HLH |
PRF1 | c.527G>A(p.Cys176Tyr) | Heterozygous | ND | |||||
15 | Female | 0.5 | Latino-Hispanic | PRF1 | c.50del(p.Leu17fs) | Heterozygous | 0.033 | Absent perforin expression |
PRF1 | c.659G>A(p.Gly220Asp) | Heterozygous | 0.0008 | |||||
16 | Female | 0.2 | African American | PRF1 | c.50del(p.Leu17fs) | Heterozygous | 0.033 | Absent NK cell function |
PRF1 | c.853_855del(p.Lys285del) | Heterozygous | 0.0056 | |||||
17 | Male | 66 d | Unknown | PRF1 | c.50del(p.Leu17fs) | Heterozygous | 0.033 | NA |
PRF1 | c.895C>T(p.Arg299Cys) | Heterozygous | 0.0012 | |||||
18 | Male | 20.6 | Latino-Hispanic | PRF1 | c.50del(p.Leu17fs) | Heterozygous | 0.033 | NA |
PRF1 | c.902C>T(p.Ser301Leu) | Heterozygous | ND | |||||
19 | Male | 54 d | African American | PRF1 | c.50del(p.Leu17fs) | Heterozygous | 0.033 | Symptoms of HLH |
PRF1 | c.916G>T(p.Gly306Cys) | Heterozygous | ND | |||||
20 | Female | 45 d | African American | PRF1 | c.50del(p.Leu17fs) | Heterozygous | 0.033 | Absent perforin expression |
PRF1 | c.916G>T(p.Gly306Cys) | Heterozygous | ND | |||||
21 | Male | 32 d | Latino-Hispanic | PRF1 | c.50del(p.Leu17fs) | Heterozygous | 0.033 | Symptoms of HLH |
PRF1 | c.985dup(p.Val329fs) | Heterozygous | ND | |||||
22 | Male | 0.3 | African American | PRF1 | c.50del(p.Leu17fs) | Heterozygous | 0.033 | Absent perforin expression |
PRF1 | c.1385C>A(p.Ser462*) | Heterozygous | ND | |||||
23 | Male | 36.1 | Unknown | PRF1 | c.116C>A(p.Pro39His) | Heterozygous | 0.00081 | NA |
PRF1 | c.445G>A(p.Gly149Ser) | Heterozygous | 0.014 | |||||
24 | Female | 1.2 | Asian-American | PRF1 | c.133G>A(p.Gly45Arg) | Homozygous | 0.0012 | Absent NK cell function |
25 | Female | 37 d | Non-Hispanic white | PRF1 | c.150del(p.Thr51fs) | Heterozygous | 0.0004 | Absent perforin expression |
PRF1 | c.227G>A(p.Cys76Tyr) | Heterozygous | 0.00071 | |||||
26 | Male | 69 d | Latino-Hispanic | PRF1 | c.218G>C(p.Cys73Ser) | Homozygous | 0.0004 | Symptoms of HLH |
27 | Female | 20 | European-American | PRF1 | c.227G>A(p.Cys76Tyr) | Heterozygous | 0.00071 | Absent perforin expression |
PRF1 | c.626A>C(p.Gln209Pro) | Heterozygous | 0.0012 | |||||
28 | Female | 21.8 | Unknown | PRF1 | c.272C>T(p.Ala91Val)‡ | Heterozygous | 2.92 | Absent NK cell function, decreased perforin expression |
PRF1 | c.445G>A(p.Gly149Ser) | Heterozygous | 0.014 | |||||
29 | Male | 17 | European-American | PRF1 | c.272C>T(p.Ala91Val)‡ | Heterozygous | 2.92 | Absent perforin expression |
PRF1 | c.635A>C(p.Tyr212Ser) | Heterozygous | ND | |||||
30 | Female | 41.2 | European-American | PRF1 | c.272C>T(p.Ala91Val)‡ | Heterozygous | 2.92 | Absent NK cell function, decreased perforin expression |
PRF1 | c.666C>A(p.His222Gln) | Heterozygous | 0.0039 | |||||
31 | Female | 8.3 | European-American | PRF1 | c.443C>G(p.Ala148Gly) | Heterozygous | 0.0004 | NA |
PRF1 | c.666C>A(p.His222Gln) | Heterozygous | 0.0039 | |||||
32 | Male | 2.6 | Unknown | PRF1 | c.445G>A(p.Gly149Ser) | Homozygous | 0.014 | Absent NK cell function |
33 | Male | 0.8 | Latino-Hispanic | PRF1 | c.445G>A(p.Gly149Ser) | Homozygous | 0.014 | Symptoms of HLH |
34 | Female | 6 | Latino-Hispanic | PRF1 | c.445G>A(p.Gly149Ser) | Homozygous | 0.014 | NA |
35 | Female | 0.3 | European-American | PRF1 | c.445G>A(p.Gly149Ser) | Heterozygous | 0.014 | Family history of HLH |
PRF1 | c.614A>G(p.Asn205Ser) | Heterozygous | 0.0043 | |||||
36 | Male | 42 d | Latino-Hispanic | PRF1 | c.445G>A(p.Gly149Ser) | Heterozygous | 0.014 | NA |
PRF1 | c.938A>T(p.Asp313Val) | Heterozygous | 0.0012 | |||||
37 | Male | 4.6 | Unknown | PRF1 | c.445G>A(p.Gly149Ser) | Heterozygous | 0.014 | Absent perforin expression |
PRF1 | c.1081A>T(p.Arg361Trp) | Heterozygous | 0.0011 | |||||
38 | Female | 32 d | Middle Eastern | PRF1 | c.501C>G(p.Tyr167*) | Homozygous | ND | Symptoms of HLH |
39 | Female | 0.3 | Unknown | PRF1 | c.512C>A(p.Thr171Asn) | Homozygous | 0.0028 | Absent perforin expression |
40 | Male | 9.5 | European-American | PRF1 | c.786_801del(p.Gln263fs) | Heterozygous | ND | Absent NK cell function |
PRF1 | c.886T>C(p.Tyr296His) | Heterozygous | 0.0012 | |||||
41 | Male | 59 d | Unknown | PRF1 | c.853_855del(p.Lys285del) | Heterozygous | 0.0057 | NA |
PRF1 | c.921del(p.His308fs) | Heterozygous | 0.002 | |||||
42 | Female | 0.7 | Middle Eastern | PRF1 | c.880del(p.Gln294fs) | Homozygous | ND | Symptoms of HLH |
43 | Female | 2 | Middle Eastern | PRF1 | c.895C>T(p.Arg299Cys) | Homozygous | 0.0012 | Symptoms of HLH |
44 | Female | 0.2 | Latino-Hispanic | PRF1 | c.904G>T(p.Glu302*) | Homozygous | ND | Absent perforin expression |
45 | Female | 1.8 | Unknown | PRF1 | c.949G>A(p.Gly317Arg) | Homozygous | 0.0008 | Symptoms of HLH |
46 | Female | 10.3 | European-American | PRF1 | c.973T>C(p.Tyr325His) | Heterozygous | ND | Absent perforin expression |
PRF1 | c.1326_1328del(p.Phe443del) | Heterozygous | ND | |||||
47 | Male | 1.1 | Middle Eastern | PRF1 | c.1070G>C(p.Arg357Pro) | Homozygous | ND | Symptoms of HLH |
48 | Male | 12.5 | Middle Eastern | PRF1 | c.1081A>T(p.Arg361Trp) | Homozygous | 0.0011 | Abnormal brain lesions and seizures |
49 | Female | 2.6 | Unknown | PRF1 | c.1229_1230delinsCC (p.Arg410Pro) | Homozygous | ND | NA |
50 | Female | 0.2 | African American | PRF1 | c.1304C>T(p.Thr435Met) | Heterozygous | 0.0028 | Absent perforin expression |
PRF1 | c.1314T>A(p.Tyr438*) | Heterozygous | 0.0032 | |||||
51 | Female | 2.6 | Latino-Hispanic | PRF1 | c.1337A>C(p.Gln446Pro) | Homozygous | 0.0016 | NA |
52 | Female | 2.6 | Unknown | PRF1 | c.1337A>C(p.Gln446Pro) | Homozygous | 0.0016 | Symptoms of HLH |
53 | Female | 0.4 | Middle Eastern | STXBP2 | c.37+2T>C | Heterozygous | ND | Absent NK cell function |
STXBP2 | c.1430C>T(p.Pro477Leu) | Heterozygous | 0.00074 | |||||
54 | Male | 0.6 | Unknown | STXBP2 | c.37+5G>A | Heterozygous | ND | NA |
STXBP2 | c.1057T>C (p.Cys353Arg) | Heterozygous | 0.0004 | |||||
55 | Female | 63 d | Asian-American | STXBP2 | c.193C>T(p.Arg65Trp) | Homozygous | 0.00071 | Absent NK cell function |
56 | Female | 5.5 | Unknown | STXBP2 | c.194G>A(p.Arg65Gln) | Heterozygous | 0.0028 | Absent NK cell function |
STXBP2 | c.560C>T (p.Pro187Leu) | Heterozygous | 0.00064 | |||||
57 | Male | 4.1 | European-American | STXBP2 | c.194G>A(p.Arg65Gln) | Heterozygous | 0.0028 | Symptoms of HLH |
STXBP2 | c.1621G>A(p.Gly541Ser) | Heterozygous | 0.023 | |||||
58 | Female | 4.2 | European-American | STXBP2 | c.326-30_326-23del | Heterozygous | 0.0068 | Symptoms of HLH |
STXBP2 | c.1621G>A(p.Gly541Ser) | Heterozygous | 0.023 | |||||
59 | Male | 0.6 | Latino-Hispanic | STXBP2 | c.389T>C(p.Leu130Ser) | Homozygous | 0.0032 | Symptoms of HLH |
60 | Male | 45 d | African American | STXBP2 | c.389T>C(p.Leu130Ser) | Heterozygous | 0.0032 | Symptoms of HLH; family history of HLH |
STXBP2 | exon 14-19 deletion | Heterozygous | ND | |||||
61 | Male | 0.7 | Middle Eastern | STXBP2 | c.481del(p.Arg161fs) | Homozygous | ND | Symptoms of HLH |
62 | Male | 0.4 | Unknown | STXBP2 | c.481del(p.Arg161fs) | Homozygous | ND | Symptoms of HLH |
63 | Female | 11 | European-American | STXBP2 | c.539_540delinsAA(p.Cys180*) | Heterozygous | ND | Symptoms of HLH |
STXBP2 | c.1247-1G>C | Heterozygous | 0.02 | |||||
64 | Male | 0.3 | Latino-Hispanic | STXBP2 | c.703C>G(p.Arg235Gly) | Homozygous | 0.00071 | Absent NK cell function |
65 | Female | 52.7 | European-American | STXBP2 | c.752C>T(p.Ala251Val) | Heterozygous | ND | Symptoms of HLH |
STXBP2 | c.1621G>A(p.Gly541Ser) | Heterozygous | 0.023 | |||||
66 | Male | 0.9 | Unknown | STXBP2 | c.902+5G>A | Heterozygous | 0.0036 | NA |
STXBP2 | c.1247-1G>C | Heterozygous | 0.02 | |||||
67 | Male | 3.1 | Unknown | STXBP2 | c.1247-1G>C | Homozygous | 0.02 | Symptoms of HLH |
68 | Female | 22.7 | Latino-Spanish | STXBP2 | c.1247-1G>C | Homozygous | 0.02 | Decreased NK cell function |
69 | Male | 26.4 | European-American | STXBP2 | c.1247-1G>C | Homozygous | 0.02 | Symptoms of HLH |
70 | Male | 25.6 | European-American | STXBP2 | c.1247-1G>C | Homozygous | 0.02 | Symptoms of HLH |
71 | Female | 29.7 | European-American | STXBP2 | c.1247-1G>C | Homozygous | 0.02 | NA |
72 | Male | 4 | European-American | STXBP2 | c.1247-1G>C | Heterozygous | 0.02 | Absent NK cell function |
STXBP2 | c.1621G>A(p.Gly541Ser) | Heterozygous | 0.023 | |||||
73 | Female | 15.8 | European-American | STXBP2 | c.1247-1G>C | Heterozygous | 0.02 | Absent NK cell function |
STXBP2 | c.1621G>A(p.Gly541Ser) | Heterozygous | 0.023 | |||||
74 | Female | 19 | Unknown | STXBP2 | c.1247-1G>C | Heterozygous | 0.02 | Decreased NK cell function |
STXBP2 | c.1621G>A(p.Gly541Ser) | Heterozygous | 0.023 | |||||
75 | Female | 26.9 | European-American | STXBP2 | c.1247-1G>C | Heterozygous | 0.02 | Symptoms of HLH |
STXBP2 | c.1621G>A(p.Gly541Ser) | Heterozygous | 0.023 | |||||
76 | Female | 57.8 | European-American | STXBP2 | c.1247-1G>C | Heterozygous | 0.02 | Absent NK cell function |
STXBP2 | c.1621G>A(p.Gly541Ser) | Heterozygous | 0.023 | |||||
77 | Female | 0.2 | Middle Eastern | STXBP2 | c.1430C>T(p.Pro477Leu) | Homozygous | 0.00074 | Symptoms of HLH |
78 | Female | 0.3 | Middle Eastern | STXBP2 | c.1430C>T(p.Pro477Leu) | Homozygous | 0.00074 | NA |
79 | Female | 0.3 | Middle Eastern | STXBP2 | c.1430C>T(p.Pro477Leu) | Homozygous | 0.00074 | Symptoms of HLH |
80 | Female | 0.6 | Middle Eastern | STXBP2 | c.1430C>T(p.Pro477Leu) | Homozygous | 0.00074 | Symptoms of HLH |
81 | Male | 0.2 | Middle Eastern | STXBP2 | c.1430C>T(p.Pro477Leu) | Homozygous | 0.00074 | NA |
82 | Male | 0.7 | Middle Eastern | STXBP2 | c.1430C>T(p.Pro477Leu) | Homozygous | 0.00074 | Symptoms of HLH |
83 | Female | 0.8 | Middle Eastern | STXBP2 | c.1430C>T(p.Pro477Leu) | Homozygous | 0.00074 | Symptoms of HLH |
84 | Male | 0.8 | Unknown | STXBP2 | c.1430C>T(p.Pro477Leu) | Homozygous | 0.00074 | Symptoms of HLH |
85 | Male | 0.6 | Unknown | STXBP2 | c.1430C>T(p.Pro477Leu) | Homozygous | 0.00074 | Family history of HLH |
86 | Male | 1.6 | Middle Eastern | STXBP2 | c.1430C>T(p.Pro477Leu) | Homozygous | 0.00074 | Symptoms of HLH |
87 | Male | 0.3 | Middle Eastern | STXBP2 | c.1430C>T(p.Pro477Leu) | Homozygous | 0.00074 | Symptoms of HLH |
88 | Female | 63 d | Middle Eastern | STXBP2 | c.1430C>T(p.Pro477Leu) | Homozygous | 0.00074 | Family history of HLH |
89 | Male | 0.5 | Unknown | STXBP2 | c.1430C>T(p.Pro477Leu) | Homozygous | 0.00074 | Symptoms of HLH |
90 | Male | 0.2 | Middle Eastern | STXBP2 | c.1430C>T(p.Pro477Leu) | Homozygous | 0.00074 | Symptoms of HLH |
91 | Male | 11.1 | Unknown | STXBP2 | c.1430C>T(p.Pro477Leu) | Homozygous | 0.00074 | Absent NK cell function |
92 | Female | 10.1 | Unknown | STXBP2 | c.1430C>T(p.Pro477Leu) | Heterozygous | 0.00074 | Symptoms of HLH |
STXBP2 | c.1696+5G>T | Heterozygous | ND | |||||
93 | Male | 0.5 | Middle Eastern | STXBP2 | c.1452+1G>A | Homozygous | ND | Symptoms of HLH |
94 | Male | 1 | Middle Eastern | STXBP2 | c.1452+1G>A | Homozygous | ND | Abnormal NK cell function |
95 | Female | 49 d | European-American | UNC13D | c.118-308C>T | Heterozygous | 0.019 | Dysmorphic facies, decreased NK cell function |
UNC13D | c.2258_2267delinsTACCTTGTTCGA (p.Gly753fs) | Heterozygous | ND | |||||
96 | Male | 0.7 | European-American | UNC13D | c.118-308C>T | Heterozygous | 0.019 | Decreased NK cell function |
UNC13D | c.2346_2349del(p.Arg782fs) | Heterozygous | 0.01 | |||||
97 | Male | 0.2 | European-American + Latino-Spanish | UNC13D | c.118-308C>T | Heterozygous | 0.019 | Decreased NK cell function |
UNC13D | c.2346_2349del(p.Arg782fs) | Heterozygous | 0.01 | |||||
98 | Female | 1.3 | Non-Hispanic white | UNC13D | c.118-308C>T | Heterozygous | 0.019 | Symptoms of HLH, seizures, normal NK cell function |
UNC13D | c.2867C>T(p.Pro956Leu) | Heterozygous | ND | |||||
99 | Female | 1 | Non-Hispanic white | UNC13D | c.118-308C>T | Heterozygous | 0.019 | Absent NK cell function |
UNC13D | c.3193C>T(p.Arg1065*) | Heterozygous | 0.0011 | |||||
100 | Female | 3.2 | European-American | UNC13D | c.118-308C>T | Heterozygous | 0.019 | Absent NK cell function |
UNC13D | 253Kb inversion | Heterozygous | ND | |||||
101 | Male | 2.6 | Unknown | UNC13D | 253Kb inversion | Heterozygous | ND | Decreased NK cell function |
UNC13D | c.154-1G>C | Heterozygous | ND | |||||
102 | Male | 0.2 | Unknown | UNC13D | 253Kb inversion | Heterozygous | ND | Symptoms of HLH |
UNC13D | c.551G>A(p.Trp184*) | Heterozygous | 0.0011 | |||||
103 | Female | 0.2 | European-American | UNC13D | 253Kb inversion | Heterozygous | ND | NA |
UNC13D | c.1389+1G>A | Heterozygous | 0.0071 | |||||
104 | Female | 0.2 | European-American | UNC13D | 253Kb inversion | Heterozygous | ND | Absent NK cell function |
UNC13D | c.2447+1G>A | Heterozygous | 0.00051 | |||||
105 | Female | 0.6 | Non-Hispanic white | UNC13D | 253Kb inversion | Heterozygous | ND | Decreased NK cell function |
UNC13D | c.2695C>T(p.Arg899*) | Heterozygous | 0.0018 | |||||
106 | Male | 11.4 | Hispanic white | UNC13D | c.182A>G(p.Tyr61Cys) | Heterozygous | ND | Symptoms of HLH |
UNC13D | c.778T>C(p.Trp260Arg) | Heterozygous | ND | |||||
107 | Male | 0.4 | European-American | UNC13D | c.262-1G>A | Heterozygous | ND | Symptoms of HLH, abnormal NK cell function, family history of HLH |
UNC13D | c.766C>T(p.Arg256*) | Heterozygous | 0.0025 | |||||
108 | Male | 0.4 | Unknown | UNC13D | c.321+1_321+2del | Heterozygous | ND | Decreased NK cell function |
UNC13D | c.753+1G>T | Heterozygous | 0.0044 | |||||
109 | Male | 0.3 | Unknown | UNC13D | c.322-2A>T | Heterozygous | 0.0024 | Symptoms of HLH, decreased NK cell function |
UNC13D | c.2346_2349del(p.Arg782fs) | Heterozygous | 0.01 | |||||
110 | Male | 0.3 | Unknown | UNC13D | c.419T>C(p.Ile140Thr) | Heterozygous | 0.0004 | NA |
UNC13D | c.460C>T(p.Arg154Trp) | Heterozygous | 0.011 | |||||
111 | Female | 5.4 | Middle Eastern | UNC13D | c.424dup(p.Gln142fs) | Homozygous | ND | Symptoms of HLH |
112 | Male | 7.7 | Latino-Hispanic | UNC13D | c.518C>T(p.Thr173Met) | Heterozygous | 0.0028 | NA |
UNC13D | c.1803_1819dup(p.Arg607fs) | Heterozygous | ND | |||||
113 | Female | 39 d | European-American | UNC13D | c.551G>A(p.Trp184*) | Heterozygous | 0.0011 | Abnormal NK cell function |
UNC13D | c.766C>T(p.Arg256*) | Heterozygous | 0.0025 | |||||
114 | Male | 4.9 | European-American | UNC13D | c.570-2A>T | Heterozygous | ND | Absent NK cell function |
UNC13D | c.3049G>A(p.Glu1017Lys) | Heterozygous | 0.00044 | |||||
115 | Female | 0.2 | Middle Eastern | UNC13D | c.753+1G>T | Homozygous | 0.0044 | Symptoms of HLH |
116 | Female | 0.6 | European-American | UNC13D | c.766C>T(p.Arg256*) | Heterozygous | 0.0025 | Symptoms of HLH, abnormal NK cell function |
UNC13D | c.2447+1G>A | Heterozygous | 0.00051 | |||||
117 | Female | 1.2 | Latino-Spanish | UNC13D | c.859del(p.Arg287fs) | Homozygous | ND | Decreased NK cell function |
118 | Female | 1 | Non-Hispanic white | UNC13D | c.1055+1G>T | Heterozygous | ND | Decreased NK cell function, family history of HLH |
UNC13D | c.2346_2349del(p.Arg782fs) | Heterozygous | 0.01 | |||||
119 | Male | 0.7 | European-American | UNC13D | c.1229_1230dup(p.Arg411fs) | Heterozygous | 0.00 | Symptoms of HLH, hypertelorism |
UNC13D | c.2298+1G>T | Heterozygous | ND | |||||
120 | Female | 0.2 | European-American | UNC13D | c.1259_1260del(p.Ser420fs) | Heterozygous | ND | symptoms of HLH, decreased NK cell function |
UNC13D | c.1848+1G>C | Heterozygous | ND | |||||
121 | Male | 18.3 | European-American | UNC13D | c.1387C>T(p.Gln463*) | Heterozygous | ND | symptoms of HLH, decreased NK cell function |
UNC13D | c.1820G>C(p.Arg607Pro) | Heterozygous | 0.011 | |||||
122 | Female | 58 d | European-American + African American | UNC13D | c.1389+1G>A | Heterozygous | 0.0071 | Symptoms of HLH |
UNC13D | c.1848+1G>C | Heterozygous | ND | |||||
123 | Female | 0.2 | Middle Eastern | UNC13D | c.1423C>T(p.Gln475*) | Homozygous | ND | NA |
124 | Male | 10 d | Pacific Islander | UNC13D | c.2296C>T(p.Gln766*) | Homozygous | ND | Decreased NK cell function |
125 | Female | 13.2 | Unknown | UNC13D | c.2346_2349del(p.Arg782fs) | Heterozygous | 0.01 | NA |
UNC13D | c.2588G>A(p.Gly863Asp) | Heterozygous | 0.029 | |||||
126 | Female | 2 | Unknown | UNC13D | c.2346_2349del(p.Arg782fs) | Heterozygous | 0.01 | NA |
UNC13D | c.3065T>C(p.Leu1022Pro) | Heterozygous | ND | |||||
127 | Female | 0.2 | Middle Eastern | UNC13D | c.2553+1G>T | Homozygous | ND | Symptoms of HLH |
128 | Female | 0.3 | Middle Eastern | UNC13D | c.2553+1G>T | Homozygous | ND | Symptoms of HLH |
129 | Female | 1 | Asian | UNC13D | c.2588G>A(p.Gly863Asp) | Homozygous | 0.029 | Decreased NK cell function |
130 | Female | 0.4 | African American | UNC13D | c.2695C>T(p.Arg899*) | Homozygous | 0.0018 | Symptoms of HLH, absent NK cell function, dysmorphic facies |
131 | Male | 0.7 | Non-Hispanic white | UNC13D | c.2819del(p.Leu940fs) | Homozygous | ND | symptoms of HLH |
132 | Female | 0.6 | Middle Eastern | UNC13D | c.3048dup(p.Glu1017fs) | Homozygous | ND | NA |
133 | Female | 0.7 | Unknown | UNC13D | c.3053C>A(p.Ala1018Asp) | Homozygous | 0.00088 | 2 affected siblings |
134 | Male | 13 | European-American | RAB27A | c.121A>G(p.Thr41Ala) | Heterozygous | ND | NA |
RAB27A | c.352C>T(p.Gln118*) | Heterozygous | ND | |||||
135 | Male | 9.6 | Middle Eastern | RAB27A | c.244C>T(p.Arg82Cys) | Homozygous | 0.0016 | NA |
136 | Male | 9.9 | Middle Eastern | RAB27A | c.244C>T(p.Arg82Cys) | Homozygous | 0.0016 | NA |
137 | Female | 2 | Middle Eastern | RAB27A | c.244C>T(p.Arg82Cys) | Homozygous | 0.0016 | Failure to thrive, bone marrow failure |
138 | Female | 9.4 | Middle Eastern | RAB27A | c.244C>T(p.Arg82Cys) | Homozygous | 0.0016 | Symptoms of HLH |
139 | Male | 10.6 | Middle Eastern | RAB27A | c.244C>T(p.Arg82Cys) | Homozygous | 0.0016 | Symptoms of HLH |
140 | Male | 19.5 | Middle Eastern | RAB27A | c.244C>T(p.Arg82Cys) | Homozygous | 0.0016 | Symptoms of HLH |
141 | Female | 0.3 | Latino-Hispanic | RAB27A | c.335del(p.Asn112fs) | Homozygous | 0.0044 | Symptoms of HLH |
142 | Female | 0.4 | Middle Eastern | RAB27A | c.400A>C(p.Lys134Gln) | Homozygous | ND | NA |
143 | Female | 53.9 | Pacific Islander | RAB27A | c.476A>G(p.Tyr159Cys) | Homozygous | ND | Symptoms of HLH, absent NK cell function |
144 | Male | 1.2 | Middle Eastern | RAB27A | c.598C>T(p.Arg200*) | Homozygous | 0.0004 | NA |
145 | Female | 0.4 | European-American | RAB27A | c.638_642del(p.Glu213fs) | Homozygous | 0.0008 | Symptoms of HLH |
146 | Female | 0.7 | African American | LYST | c.925C>T(p.Arg309*) | Heterozygous | ND | Oculocutaneous albinism, neutropenia |
LYST | c.2015dup(p.Tyr672*) | Heterozygous | ND | |||||
147 | Male | 3.4 | Unknown | LYST | c.3194del(p.Leu1065*) | Homozygous | 0.0004 | NA |
148 | Female | 0.3 | Middle Eastern | LYST | c.4159dup(p.Thr1387fs) | Homozygous | ND | Premature gray hair, anemia |
149 | Male | 0.9 | European-American | LYST | c.5715del(p.Asn1905fs) | Heterozygous | ND | Oculocutaneous albinism, neutropenia, absent NK cell function |
LYST | c.8802-2A>G | Heterozygous | ND | |||||
150 | Female | 6.9 | Unknown | LYST | c.5784+1G>T | Homozygous | ND | Oculocutaneous albinism, dysmorphic facies, neutropenia |
151 | Male | 3.2 | Non-Hispanic white | LYST | c.6159_6160del(p.Met2053fs) | Homozygous | ND | NA |
152 | Male | 1.8 | Middle Eastern | LYST | c.7291del(p.Leu2431fs) | Homozygous | ND | Hypopigmentation, anemia |
153 | Male | 1.2 | African American | LYST | c.8770C>T(p.Gln2924*) | Heterozygous | ND | Silver hair, hypopigmented skin lesions, pancytopenia |
LYST | c.9844_9845del(p.Ser3282fs) | Heterozygous | ND | |||||
154 | Female | 7.1 | Middle Eastern | LYST | c.10776C>G(p.Tyr3592*) | Homozygous | ND | Abnormal pigmentation, neutropenia |
155 | Female | 1.2 | Unknown | STX11 | c.73G>T(p.Glu25*) | Heterozygous | 0.0004 | Decreased NK cell function |
STX11 | c.748C>T(p.Gln250*) | Heterozygous | 0.00081 | |||||
156 | Female | 5.6 | Middle Eastern | STX11 | c.173T>C(p.Leu58Pro) | Homozygous | 0.0008 | Symptoms of HLH, grayish hair |
157 | Female | 11.6 | Middle Eastern | STX11 | c.173T>C(p.Leu58Pro) | Homozygous | 0.0008 | NA |
158 | Male | 2.9 | European-American + Latino-Hispanic | STX11 | c.462_463delinsA(p.Asp155fs) | Heterozygous | ND | Decreased NK cell function |
STX11 | c.784C>T(p.Gln262*) | Heterozygous | ND | |||||
159 | Male | 1.4 | Asian-Indian | STX11 | c.687dup(p.Gln230fs) | Homozygous | ND | NA |
160 | Female | 12 d | Middle Eastern | SLC7A7 | c.1429+1G>C | Homozygous | ND | Family history of HLH |
161 | Male | 1.2 | African American | SLC7A7 | c.701del(p.Ser234fs) | Heterozygous | 0.0016 | NA |
SLC7A7 | c.895-1G>A | Heterozygous | ND | |||||
162 | Female | 13.7 | European-American | SLC7A7 | c.360_361delinsAA (p.Trp121Arg) | Homozygous | ND | NA |
163 | Male | 5.4 | African American | XIAP | c.145C>T(p.Arg49*) | Hemizygous | ND | Markedly decreased XIAP expression |
164 | Male | 18.7 | European-American | XIAP | c.345C>G(p.Tyr115*) | Hemizygous | ND | Symptoms of HLH |
165 | Male | 30.3 | European-American | XIAP | c.608G>T(p.Cys203Phe) | Hemizygous | ND | NA |
166 | Male | 2 | European-American | XIAP | c.664C>T(p.Arg222*) | Hemizygous | ND | Symptoms of HLH |
167 | Male | 8.9 | European-American | XIAP | c.738del(p.Asp247fs) | Hemizygous | ND | NA |
168 | Male | 16 | European-American | XIAP | c.738del(p.Asp247fs) | Hemizygous | ND | Absent XIAP expression |
169 | Male | 3.6 | African American | XIAP | c.889A>T(p.Lys297*) | Hemizygous | ND | NA |
170 | Male | 0.4 | Unknown | XIAP | c.894_898del(p.Lys299fs) | Hemizygous | ND | NA |
171 | Male | 17.2 | European-American | XIAP | c.894_898del(p.Lys299fs) | Hemizygous | ND | Symptoms of HLH |
172 | Male | 19.6 | African American | XIAP | c.926_929del(p.Asp309fs) | Hemizygous | ND | Symptoms of HLH |
173 | Male | 17.2 | European-American | XIAP | c.969G>A(p.Trp323*) | Hemizygous | ND | Decreased XIAP expression |
174 | Male | 22.6 | Unknown | XIAP | c.1021_1022del(p.Asn341fs) | Hemizygous | ND | NA |
175 | Male | 4.5 | Unknown | XIAP | c.1056+1G>A | Hemizygous | ND | NA |
176 | Male | 2.7 | Latino-Hispanic | XIAP | c.1141C>T(p.Arg381*) | Hemizygous | ND | NA |
177 | Male | 11.8 | Unknown | XIAP | c.1141C>T(p.Arg381*) | Hemizygous | ND | Absent XIAP expression |
178 | Male | 1 d | Pacific-Islander | XIAP | c.1239_1242dup(p.Val415fs) | Hemizygous | ND | Markedly decreased XIAP expression |
179 | Male | 1.9 | Unknown | XIAP | c.1239_1242dup(p.Val415fs) | Hemizygous | ND | NA |
180 | Male | 1.1 | Unknown | XIAP | c.1301-1G>A | Hemizygous | ND | Symptoms of HLH |
181 | Male | 1.5 | Unknown | XIAP | c.1445C>G(p.Pro482Arg) | Hemizygous | ND | NA |
182 | Male | 35 | European-American | XIAP | c.1456dup(p.Thr486fs) | Hemizygous | ND | Symptoms of HLH |
183 | Male | 4.5 | European-American | SH2D1A | c.20A>G(p.Tyr7Cys) | Hemizygous | ND | Absent SAP in CD8+ T cells |
184 | Male | 1.8 | Unknown | SH2D1A | c.117C>T(p.Gly39Gly) | Hemizygous | ND | NA |
185 | Male | 3.5 | Unknown | SH2D1A | c.130T>C(p.Cys44Arg) | Hemizygous | ND | Absent SAP in CD8+ T cells |
186 | Male | 27 | European-American | SH2D1A | c.163C>T(p.Arg55*) | Hemizygous | ND | History of pneumonia |
187 | Male | 8 d | Unknown | SH2D1A | c.172C>T(p.Gln58*) | Hemizygous | ND | NA |
188 | Male | 6.8 | African American | SH2D1A | c.172C>T(p.Gln58*) | Hemizygous | ND | Absent SAP in CD8+ T cells |
189 | Male | 4.7 | Latino-Hispanic | SH2D1A | c.199_201+19del(p.Glu67del) | Hemizygous | ND | Absent SAP in CD8+ T cells |
190 | Male | 1.3 | African American | SH2D1A | c.201G>A(p.Glu67Glu) | Hemizygous | ND | Absent SAP in CD8+ T cells |
191 | Male | 7 d | European-American | SH2D1A | c.245del(p.Asn82fs) | Hemizygous | ND | Absent SAP in CD8+ T cells |
192 | Male | 34 d | European-American + Pacific-Islander | SH2D1A | c.295C>T(p.Gln99*) | Hemizygous | ND | Absent SAP in CD8+ T cells |
193 | Male | 5.4 | Middle-Eastern | MAGT1 | c.154_161delinsC(p.Ile52fs) | Hemizygous | ND | Symptoms of HLH, bone pain in low extremities |
194 | Male | 10.4 | European-American | MAGT1 | c.223C>T(p.Gln75*) | Hemizygous | ND | NA |
195 | Male | 18.4 | African American | MAGT1 | c.407G>A(p.Trp136*) | Hemizygous | ND | NA |
196 | Male | 27.6 | European-American | MAGT1 | c.443_444del(p.Phe148fs) | Hemizygous | ND | Symptoms of HLH |
197 | Male | 17.3 | European-American | MAGT1 | c.774del(p.Phe258fs) | Hemizygous | ND | NA |
NA, no data; ND, no data; NK, natural killer.
gnomAD v2.1.1 total population frequency.
HLH hemophagocytic lymphohistiocytosis, symptoms of HLH reported included any or all of the following “fever, hepatosplenomegaly, anemia/cytopenias, neutropenia/leukopenia, elevated ferritin/triglycerides, and/or decreased fibrinogen.”
According to the ACMG guideline, c.272C>T(p.Ala91Val) in PRF1 was classified as a variant of unknown significance.